Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Aetoxisclerol: lst impressions].

P Ouvry, A Chaudet, E Guillerot

    Phlebologie
    |April 1, 1978
    PubMed
    Summary

    Polydocanol is a sclerosing agent suitable for treating spider veins and telangiectasias due to its ease of use. However, it is less effective for larger varicose veins compared to other treatments and can cause allergic reactions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Update of the SFMV (French society of vascular medicine) guidelines on the conditions and safety measures necessary for thermal ablation of the saphenous veins and proposals for unresolved issues.

    Journal de medecine vasculaire·2020
    Same author

    Journal de medecine vasculaire·2019
    Same author

    Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV).

    Journal de medecine vasculaire·2019
    Same author

    [Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV)].

    Journal de medecine vasculaire·2019
    Same author

    Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery.

    British journal of anaesthesia·2014
    Same author

    [Questions--answers on the use of rivaroxaban for the treatment of venous thromboembolic disease].

    Journal des maladies vasculaires·2012

    Area of Science:

    • Vascular Medicine
    • Dermatology
    • Phlebology

    Context:

    • Polydocanol is a recently introduced sclerosing agent in France.
    • Varicose vein treatment options are continually evolving.
    • Patient comfort and treatment efficacy are key considerations.

    Purpose:

    • To evaluate the efficacy and safety of polydocanol in treating varicose veins.
    • To compare polydocanol with existing sclerosing agents like iodine and trombovar.
    • To identify the optimal applications for polydocanol in vascular treatments.

    Summary:

    • Polydocanol demonstrates lower efficacy for large or medium varicose veins compared to iodine or trombovar.
    • Its pleasant application makes it preferable for treating varicosities and telangiectasias.
    • Potential for allergic reactions exists with polydocanol, similar to other sclerosing agents.

    Impact:

    • Provides insights into the comparative effectiveness of polydocanol.
    • Guides clinical decisions regarding the use of polydocanol for specific vascular conditions.
    • Highlights the need for continued monitoring of adverse events associated with polydocanol therapy.

    Related Experiment Videos